Safety and efficacy of a novel polyethylene glycol hydrogel sealant for watertight dural repair.

Cosgrove, G Rees; Delashaw, Johnny B; Grotenhuis, J Andre; Tew, John M; Van Loveren, Harry; Spetzler, Robert F; Payner, Troy; Rosseau, Gail et al. · J Neurosurg · 2007

prospective_cohort · Level II

Where this comes from

Abstract

The authors prospectively evaluated the safety and efficacy of a novel polyethylene glycol (PEG) hydrogel sealant in patients undergoing elective cranial surgery with documented cerebrospinal fluid (CSF) leakage after sutured dural repair. The PEG hydrogel sealant was used at 11 different study sites in 111 patients with documented intraoperative CSF leakage after neurosurgical dural repair for a variety of conditions. Intraoperative CSF leakage was either spontaneous or induced by a Valsalva maneuver. Patients were monitored for 3 months postoperatively with physical examinations, clinical laboratory analyses, and diagnostic imaging. The PEG hydrogel sealant was 100% effective in stopping CSF leakage in all patients. There were no sealant-related adverse events and all clinical outcomes were consistent with expectations for seriously ill patients undergoing prolonged neurosurgical procedures. The PEG hydrogel sealant provides a safe and effective watertight closure when used as an adjunct to sutured dural repair during cranial surgery.

Medical subject headings